AXOVANT GENE THERAPIES LTD's ticker is AXGT and the CUSIP is G0750W203. A total of 51 filers reported holding AXOVANT GENE THERAPIES LTD in Q3 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $20,000 | +150.0% | 4,330 | +44.3% | 0.00% | – |
| Q2 2020 | $8,000 | +300.0% | 3,000 | +253.4% | 0.00% | – |
| Q1 2020 | $2,000 | -84.6% | 849 | -68.5% | 0.00% | – |
| Q4 2019 | $13,000 | -56.7% | 2,691 | -43.6% | 0.00% | – |
| Q3 2019 | $30,000 | +1400.0% | 4,774 | +1267.9% | 0.00% | – |
| Q2 2019 | $2,000 | – | 349 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|